Literature DB >> 22393158

Influence of ablative margin on local tumor progression and survival in patients with HCC ≤4 cm after laser ablation.

Giampiero Francica1, Alesssandra Petrolati, Enrico Di Stasio, Sara Pacella, Roberto Stasi, Claudio Maurizio Pacella.   

Abstract

BACKGROUND: Ablation of the normal hepatic parenchyma surrounding the tumor (ablative margin [AM]) is necessary to prevent local tumor progression.
PURPOSE: To assess the prognostic value of the ablative margin in patients with HCC ≤4 cm treated with US-guided laser ablation.
MATERIAL AND METHODS: A cohort of 116 patients (53 women and 63 men, age range 42-82 years) with 132 HCC nodules ≤4 cm completely ablated by US-guided laser ablation was retrospectively analyzed. Rates of local tumor progression were compared using different ablative margin cut-offs (≥2.5, 5.0, 7.5, and 10.0 mm). Survival probability curves were obtained with the Kaplan-Meier method.
RESULTS: The mean period of follow-up was 42 months (range 3-114 months). Local tumor progression was identified in 24 out of 132 lesions (18%), with an average time to progression of 24 months (range 6-36 months). A significant difference in local tumor progression was observed only if the ablative margin was ≥7.5 mm (7% vs. 23%, P = 0.020). Survival curves of patients with or without an ablative margin ≥7.5 mm were not different (P = 0.665; mean survival time 43.8 ± 3.1 and 46.8 ± 6.1 for an AM < or ≥7.5 mm, respectively).
CONCLUSION: An ablative margin ≥7.5 mm turned out to be useful in preventing local tumor progression but did not affect long-term survival in patients with HCC ≤4 cm treated with laser ablation.

Entities:  

Mesh:

Year:  2012        PMID: 22393158     DOI: 10.1258/ar.2012.110471

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  6 in total

Review 1.  Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes.

Authors:  Mark W Dewhirst; Chelsea D Landon; Christina L Hofmann; Paul R Stauffer
Journal:  Surg Oncol Clin N Am       Date:  2013-03-13       Impact factor: 3.495

Review 2.  Laser ablation for small hepatocellular carcinoma: State of the art and future perspectives.

Authors:  Giovan Giuseppe Di Costanzo; Giampiero Francica; Claudio Maurizio Pacella
Journal:  World J Hepatol       Date:  2014-10-27

3.  Radiofrequency Ablation of Hepatic Tumor: Subjective Assessment of the Perilesional Vascular Network on Contrast-Enhanced Computed Tomography Before and After Ablation Can Reliably Predict the Risk of Local Recurrence.

Authors:  Sireesha Yedururi; Silanath Terpenning; Sanjay Gupta; Patricia Fox; Sooyoung Shin Martin; Claudius Conrad; Evelyne M Loyer
Journal:  J Comput Assist Tomogr       Date:  2017 Jul/Aug       Impact factor: 1.826

4.  Comparative evaluation of percutaneous laser and radiofrequency ablation in patients with HCC smaller than 4 cm.

Authors:  Antonio Orlacchio; Francesca Bolacchi; Fabrizio Chegai; Alberto Bergamini; Elisa Costanzo; Costantino Del Giudice; Mario Angelico; Giovanni Simonetti
Journal:  Radiol Med       Date:  2013-11-26       Impact factor: 3.469

5.  Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: a pilot case-control study.

Authors:  Filomena Morisco; Silvia Camera; Maria Guarino; Raffaella Tortora; Valentina Cossiga; Anna Vitiello; Gabriella Cordone; Nicola Caporaso; Giovan Giuseppe Di Costanzo
Journal:  Oncotarget       Date:  2018-04-03

6.  Treatment response and preliminary efficacy of hepatic tumour laser ablation under the guidance of percutaneous and endoscopic ultrasonography.

Authors:  Weilu Chai; Qiyu Zhao; Huiming Song; Chao Cheng; Guo Tian; Tian'an Jiang
Journal:  World J Surg Oncol       Date:  2019-08-05       Impact factor: 2.754

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.